Chemo-Pharma Laboratories Ltd - Stock Valuation and Financial Performance

BSE: 506365 | NSE: | Pharmaceuticals & Drugs | Small Cap

Chemo Pharma Labs Share Price

65 1.72 2.72%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on Chemo Pharma Labs

M-Cap below 100cr DeciZen not available

Chemo-Pharma Laboratories stock performance -

mw4me loader
P/E Ratio (SA):
7.25
Market Cap:
9.8 Cr.
52-wk low:
27.2
52-wk high:
84.6

Is Chemo-Pharma Laboratories Ltd an attractive stock to invest in?

1. Is Chemo-Pharma Laboratories Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Chemo-Pharma Laboratories Ltd is a below average quality company.

2. Is Chemo-Pharma Laboratories Ltd undervalued or overvalued?

The key valuation ratios of Chemo-Pharma Laboratories Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Chemo-Pharma Laboratories Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Chemo-Pharma Laboratories Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Chemo Pharma Labs:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Chemo-Pharma Laboratories Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 5%5.5%4.1%14.6%1%2%4%2.3%4.2%3%-
Value Creation
Index
-0.6-0.6-0.70.0-0.9-0.9-0.7-0.8-0.7-0.8-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 00000000000
Sales YoY Gr.-NANANANANANANANANA-
Adj EPS 1.61.91.57.60.71.42.81.73.22.39
YoY Gr.-16.2%-22.5%424.1%-91.2%106%105.1%-41%90.4%-29.3%-
BVPS (₹) 32.334.135.666.867.568.971.673.37777.487.3
Adj Net
Profit
0.20.30.21.10.10.20.40.30.50.31
Cash Flow from Ops. -0.2-0.1-0.46.4-1.7-5.54.8-0.4-0.3-0.7-
Debt/CF from Ops. -0.7-2.3-0.30000000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANANA
Adj EPS 3.8%27.4%-7.4%-29.3%
BVPS10.2%2.8%2.6%0.4%
Share Price 11.7% 43.7% 53.9% 62.9%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
5.15.64.214.81242.34.22.910.9
Op. Profit
Mgn %
0000000000NAN
Net Profit
Mgn %
0000000000INF
Debt to
Equity
0000000000-
Working Cap
Days
00000000000
Cash Conv.
Cycle
00000000000

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 10.90%

Sales growth has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Chemo-Pharma Laboratories Ltd.

Standalone Consolidated
TTM EPS (₹) 9 -9.7
TTM Sales (₹ Cr.) 0 0
BVPS (₹.) 87.3 0
Reserves (₹ Cr.) 12 2
P/BV 0.74 0.00
PE 7.25 0.00
From the Market
52 Week Low / High (₹) 27.17 / 84.60
All Time Low / High (₹) 1.60 / 195.00
Market Cap (₹ Cr.) 9.8
Equity (₹ Cr.) 1.5
Face Value (₹) 10
Industry PE 48.2

Management X-Ray of Chemo Pharma Labs:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Chemo Pharma Labs

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales0000000000
Operating Expenses 0.130.120.170.270.340.560.480.330.500.61
Manufacturing Costs000000.020.02000
Material Costs0000000000
Employee Cost 00.010.030.060.130.210.160.090.140.07
Other Costs 0.130.110.140.220.210.330.300.240.360.55
Operating Profit -0.13-0.12-0.17-0.27-0.34-0.56-0.48-0.33-0.50-0.61
Operating Profit Margin (%) ----------
Other Income 0.440.500.495.611.110.8210.670.880.71
Interest 0000000000.01
Depreciation 0000000.020.020.020.01
Exceptional Items 0000000000
Profit Before Tax 0.300.380.325.340.760.250.490.310.360.07
Tax 0.060.100.100.650.660.050.080.06-0.200.03
Profit After Tax 0.240.280.224.680.100.210.420.250.560.05
PAT Margin (%) ----------
Adjusted EPS (₹)1.61.91.531.20.71.42.81.73.70.3
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 4.855.125.3410.0210.1210.3310.7410.9911.5511.60
Share Capital 1.501.501.501.501.501.501.501.501.501.50
Reserves 3.353.623.848.528.628.839.249.4910.0510.10
Minority Interest0000000000
Debt0.120.120.120.12000000
Long Term Debt0.120.120.120.12000000
Short Term Debt0000000000
Trade Payables0000000000
Others Liabilities 0.230.340.080.580.130.090.220.06-0.15-0.22
Total Liabilities 5.205.585.5310.7210.2610.4210.9711.0511.4011.38

Fixed Assets

Gross Block0.090.090.090.090.010.010.110.110.110.11
Accumulated Depreciation0.070.080.080.0800.010.030.060.070.09
Net Fixed Assets0.01000.01000.070.050.040.03
CWIP 0000000000
Investments 1.681.681.680.020.020.040.020.042.943.03
Inventories0000000000
Trade Receivables0000000000
Cash Equivalents 0.170.380.446.877.662.978.8110.876.196.06
Others Assets3.333.513.413.822.577.412.060.092.242.27
Total Assets 5.205.585.5310.7210.2610.4210.9711.0511.4011.38

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity -0.17-0.05-0.436.41-1.66-5.484.83-0.41-0.33-0.68
PBT 0.300.380.325.340.760.250.490.310.360.07
Adjustment -0.43-0.50-0.49-0.52-1.08-0.80-0.97-0.51-0.65-0.70
Changes in Working Capital 0.010.14-0.182.25-0.68-4.895.39-0.130.02-0.05
Tax Paid -0.04-0.08-0.08-0.65-0.66-0.05-0.08-0.09-0.06-0.01
Cash Flow From Investing Activity 0.140.250.490.521.080.791.01-0.190.970.63
Capex 0000000000
Net Investments 00000-0.020.01-0.720.30-0.08
Others 0.140.250.490.521.080.8010.530.670.71
Cash Flow From Financing Activity 000-0.501.37001.96-2.12-0.08
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 0000000000
Dividend Paid 0000000000
Others 000-0.501.37001.96-2.12-0.08
Net Cash Flow -0.030.200.066.430.79-4.705.841.36-1.49-0.13
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)5.15.614.1560.9912.023.942.34.970.41
ROCE (%)6.227.525.9668.417.542.54.692.863.240.74
Asset Turnover Ratio0000000000
PAT to CFO Conversion(x)-0.71-0.18-1.951.37-16.6-26.111.5-1.64-0.59-13.6
Working Capital Days
Receivable Days0000000000
Inventory Days0000000000
Payable Days0000000000

Chemo-Pharma Laboratories Ltd Stock News

Chemo-Pharma Laboratories Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Chemo Pharma Labs on 28-Mar-2024 16:01 is ₹65.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of Chemo Pharma Labs stood at ₹9.75.
The latest P/E ratio of Chemo Pharma Labs as of 28-Mar-2024 16:01 is 7.25.
The latest P/B ratio of Chemo Pharma Labs as of 28-Mar-2024 16:01 is 0.74.
The 52-week high of Chemo Pharma Labs is ₹84.60 and the 52-week low is ₹27.17.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Chemo Pharma Labs is ₹0.00 ( Cr.) .

About Chemo-Pharma Laboratories Ltd

Chemo Pharma Laboratories has been an established company since 1942 and has been making pharmaceuticals and also had diversified into bulk drugs. However, due to increase in competition and flow of new drugs, the company had to dispose the business and pay all its liabilities and dues.

Presently the company has its own cash resource, with this the company is proposing to diversify and to take over sick company which has excellent future potential. The company is in advance negotiation to some other company and soon rehab to acquire business in power and chemicals.

The board of directors of the company has been exploring new business opportunities since manufacturing operations becoming unviable were discontinued. The company has no secured loans and has surplus funds which can be leveraged to commence any new business.

The registered office of the company is located at 5, Kumud Apartment CHS, Karnik Road, Chikan Ghar, Kalyan, Thane District, Pin Code - 421301, Maharashtra.

 

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.